These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9049597)

  • 1. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release.
    Sharp T; Gartside SE; Umbers V
    Eur J Pharmacol; 1997 Feb; 320(1):15-9. PubMed ID: 9049597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl-d-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors.
    Pallotta M; Segieth J; Whitton PS
    Brain Res; 1998 Feb; 783(2):173-8. PubMed ID: 9507110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.
    Haddjeri N; De Montigny C; Curet O; Blier P
    Eur J Pharmacol; 1998 Feb; 343(2-3):179-92. PubMed ID: 9570466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.
    Evrard A; Laporte AM; Chastanet M; Hen R; Hamon M; Adrien J
    Eur J Neurosci; 1999 Nov; 11(11):3823-31. PubMed ID: 10583471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP; Jackson DM; Wallsten C; Waszczak BL
    J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission.
    Haddjeri N; Ortemann C; de Montigny C; Blier P
    Eur Neuropsychopharmacol; 1999 Sep; 9(5):427-40. PubMed ID: 10523050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones.
    Craven R; Grahame-Smith D; Newberry N
    Eur J Pharmacol; 1994 Dec; 271(1):R1-3. PubMed ID: 7698189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
    Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
    Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization.
    Lanteri C; Hernández Vallejo SJ; Salomon L; Doucet EL; Godeheu G; Torrens Y; Houades V; Tassin JP
    J Neurosci; 2009 Jan; 29(4):987-97. PubMed ID: 19176807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing.
    Arborelius L; Wallsten C; Ahlenius S; Svensson TH
    Eur J Pharmacol; 1999 Oct; 382(2):133-8. PubMed ID: 10528148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain.
    Piñeyro G; de Montigny C; Weiss M; Blier P
    Synapse; 1996 Jan; 22(1):54-62. PubMed ID: 8822478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
    Lejeune F; Millan MJ
    Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat.
    Hajós M; Richards CD; Székely AD; Sharp T
    Neuroscience; 1998 Nov; 87(1):95-108. PubMed ID: 9722144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.
    Sprouse J; Braselton J; Reynolds L
    Biol Psychiatry; 2000 Jun; 47(12):1050-5. PubMed ID: 10862804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors.
    Bosker FJ; de Winter TY; Klompmakers AA; Westenberg HG
    J Neurochem; 1996 Jun; 66(6):2546-55. PubMed ID: 8632181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
    Matos FF; Korpinen C; Yocca FD
    Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.